Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

MTFB.L News

Motif Bio Chair Morgan Stands Down, Williams Becomes Interim Chair
18 Mar 2019

Motif Bio Chair Morgan Stands Down, Williams Becomes Interim Chair

LONDON (Alliance News) - Motif Bio PLC said Monday Chair Richard Morgan had resigned from the biopharmaceutical firm, to be replaced by biopharma vete...

Amphion Innovations Sells Partner's Motif Bio Shares In Loan Repayment (ALLISS)
15 Mar 2019

Amphion Innovations Sells Partner's Motif Bio Shares In Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Friday said it sold 1.8 million shares in partner pharmaceutical company Motif Bio PLC to repay a ...

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)
11 Mar 2019

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphi...

WINNERS & LOSERS SUMMARY: Reckitt Rises After Strong Annual Results
18 Feb 2019

WINNERS & LOSERS SUMMARY: Reckitt Rises After Strong Annual Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS...

Motif Bio Will Need Fundraise After Agreeing To Repay Part of Loan
18 Feb 2019

Motif Bio Will Need Fundraise After Agreeing To Repay Part of Loan

LONDON (Alliance News) - Shares in Motif Bio PLC plunged on Monday as its subsidiary, Motif Biosciences Inc signed an amendment agreement with lender ...

Invesco Lowers Motif Bio Interest By More Than 10% (ALLISS)
15 Feb 2019

Invesco Lowers Motif Bio Interest By More Than 10% (ALLISS)

LONDON (Alliance News) - Motif Bio PLC on Friday said that Invesco Ltd has cut its stake in the company by more than 10%.Prior to Friday's deal, Inves...

Motif Bio crashes as FDA calls for more data
14 Feb 2019

Motif Bio crashes as FDA calls for more data

(Sharecast News) - Motif Bio said it will need to raise new funds after the application for its skin infections treatment, iclaprim, was refused by th...

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results
14 Feb 2019

WINNERS & LOSERS SUMMARY: ConvaTec Slumps On "Disappointing" Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNE...